Thus, it is not surprising that TP53 is the most commonly mutated gene (TCGA, 2020), including in ovarian, colorectal, esophageal, head and neck, lung, and pancreatic cancers that are the most affected sporadic human cancer types (Olivier et al., 2010). This evidence concerns the gene TP53 and cancer.